News

Fewer Massachusetts health care workers receive influenza vaccines than is required by the state; how to spot the difference between the flu and other illnesses with similar symptoms; and more of the latest flu news as we enter 2020.

A new commentary argues that given the strong safety and efficacy profile of TDF/FTC, there is not sufficient benefit to warrant changing clinician emphasis to TAF/FTC.

The prevalence of NTDs in pregnancies among women with diagnosed HIV infection was 7.0 per 10,000 live births, which was similar to that among the general population.

New legislation, cost assistance program will likely reduce transmission.

Investigators of a recently published manuscript surveyed hospitals participating in the Michigan Hospital Medicine Safety Consortium in order to evaluate contemporary practices and needs related to antibiotic stewardship.

A new study explored the differential epidemiology of VRE colonization in nursing homes, found E faecium is carried longer and more strongly associated with device use when compared with E faecalis.

Patients with COPD in an outpatient setting who had tracheobronchial colonization of Pseudomonas aeruginosa had a 47% higher risk of mortality than those who didn’t have the infection.

Infection preventionist Saskia Popescu discusses several rapid developments that have been released in this outbreak.

An international study offers new insight on cases of influenza hospitalization among pregnant women.

Over the past decade and a half, more Americans have begun to receive STD-related diagnoses and care in a primary care setting. New recommendations from the CDC aim to help ensure quality care amid the shift.

Between September 29-December 28, 2019, influenza B viruses accounted for 59.2% of influenza-positive results reported nationwide. Of these isolates, 97.9% belonged to the B/Victoria lineage.

Pan-resistant C auris isolates are defined as being resistant to the triazole class, polyene class, as well as echinocandins.

A study comparing immunogenicity, safety, and interchangeability of JENVAC to an SA 14-14-2 strain derived vaccine has found JENVAC offers statistically higher immunological measures.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of January 5, 2020.

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Roughly half of all American expectant mothers living with HIV are receiving treatments that don’t meet federal guidelines. A new study examines prescribing choices for this population.

A new study provides detailed description of newly identified BoDV-1 induced encephalitis cases, establishing the infection as a potentially lethal zoonosis which can impact immunocompromised and healthy individuals.

A closer look at the 2018 enterovirus A71 outbreak in Colorado highlights the need for non-sterile site testing to detect infections.

As of January 5, 2020 there have been 59 confirmed cases associated with the pneumonia outbreak in Wuhan city.

The FDA has approved a supplemental new drug application for micafungin for the treatment of invasive candidiasis in pediatric patients under 4 months of age.

A new study found that the estimated time from HIV seroconversion to initiation of ART was reduced by 42% between 2006 and 2015 in New York City.

Some asymptomatic carriers of C diff went on to have clinical infection themselves within a 6-month period.

A new retrospective cohort study has confirmed that rates of hospitalization for serious infections among people with substance use disorders are increasing, particularly among young people.

New findings provide insight on the mechanisms of malarial resistance, demonstrating that inactivation or mutation of Kelch13 compartment proteins reduces the parasite’s uptake of hemoglobin.

Results of a study published in Pediatrics found that 8 of 10 children with a non–β-lactam antibiotic allergy could be delabeled.

A study in JAMA Pediatrics suggests that infants exposed to Zika in utero who do not show signs of congenital Zika syndrome may still be at risk for abnormal neurodevelopmental outcomes.

A new article in Open Forum Infectious Diseases outlines practical strategies for treating opioid use disorder in the context of associated infectious diseases.

A new study is shedding light on how bioburden and patient colonization play off each other.

Viral suppression at 2 years nearly doubled for people with HIV in a medical care coordination program implemented by the Los Angeles County Division of HIV and STD Programs, a new study found.